Richard Richieri
Directeur des opérations chez AVID BIOSERVICES, INC.
Fortune : 237 790 $ au 30/04/2024
Postes actifs de Richard Richieri
Sociétés | Poste | Début | Fin |
---|---|---|---|
AVID BIOSERVICES, INC. | Directeur des opérations | 09/10/2019 | - |
Historique de carrière de Richard Richieri
Anciens postes connus de Richard Richieri
Sociétés | Poste | Début | Fin |
---|---|---|---|
Avid Bioservices, Inc. /Old/
Avid Bioservices, Inc. /Old/ Medical/Nursing ServicesHealth Services Avid Bioservices, Inc. provides specialized cell cultures for biotechnology testing. Its services include cell line optimization, cell culture and purification process development, protein characterization, process optimization, scale-up and validation, cGMP clinical and commercial manufacturing, bulk filling, aseptic filling, analytical assay development, method qualification and validation, QC release and stability testing and regulatory strategy and submission. The company was founded by Steven W. King in 2001 and is headquartered in Tustin, CA. | Corporate Officer/Principal | - | 01/07/2011 |
SYNGENE INTERNATIONAL LIMITED | Corporate Officer/Principal | - | - |
XOMA CORPORATION | Corporate Officer/Principal | - | - |
Formation de Richard Richieri
University of California, Los Angeles | Undergraduate Degree |
University of California San Diego | Graduate Degree |
Statistiques
Internationale
Etats-Unis | 6 |
Inde | 2 |
Opérationnelle
Corporate Officer/Principal | 3 |
Undergraduate Degree | 1 |
Graduate Degree | 1 |
Sectorielle
Health Technology | 3 |
Consumer Services | 3 |
Health Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 3 |
---|---|
XOMA CORPORATION | Health Technology |
AVID BIOSERVICES, INC. | Health Technology |
SYNGENE INTERNATIONAL LIMITED | Commercial Services |
Entreprise privées | 1 |
---|---|
Avid Bioservices, Inc. /Old/
Avid Bioservices, Inc. /Old/ Medical/Nursing ServicesHealth Services Avid Bioservices, Inc. provides specialized cell cultures for biotechnology testing. Its services include cell line optimization, cell culture and purification process development, protein characterization, process optimization, scale-up and validation, cGMP clinical and commercial manufacturing, bulk filling, aseptic filling, analytical assay development, method qualification and validation, QC release and stability testing and regulatory strategy and submission. The company was founded by Steven W. King in 2001 and is headquartered in Tustin, CA. | Health Services |
- Bourse
- Insiders
- Richard Richieri
- Expérience